Clinical Trials Logo

Filter by:
NCT ID: NCT06425705 Completed - Clinical trials for Type 2 Diabetes Mellitus

Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors

Start date: February 25, 2022
Phase: Phase 2
Study type: Interventional

Given the inadequacies of existing pharmacological interventions for diabetic nephropathy, this study is predicated on the hypothesis that silymarin, having shown promise in mitigating hyperglycemia in diabetic patients without nephropathy and displaying renal protective effects in animal models, merits a thorough and systematic investigation. The current body of research on silymarin, particularly human trials, is limited by small cohorts and the preliminary nature of its outcomes. This research aims to evaluate the efficacy of silymarin as an adjunctive treatment in patients with Type 2 diabetes mellitus (T2DM) already on renin-angiotensin system inhibitors, focusing on its potential to reduce proteinuria and improve renal function. The ultimate objective is to amass more definitive evidence that could potentially inform a new therapeutic approach in the management of diabetic nephropathy.

NCT ID: NCT06424600 Completed - Smoking Clinical Trials

Ginglival Health Among Smokers Visiting Dental Hospital

Start date: February 3, 2023
Phase:
Study type: Observational

The effect of different forms of nicotine intake on the gingival health of dental patients that visited a public sector in Islamabad. A total of 300 dental patients that visited School of Dentistry, Islamabad. The nicotine consuming participants involved in this study were Smoke-Form users, E cigarette-form users, and Dual-Form users whose Gingival Index (G-I) was inspected to demonstrate an association between their smoking type and duration of developing severe gingivitis.

NCT ID: NCT06424028 Recruiting - Clinical trials for Right Ventricular Dysfunction

Acute Right Ventricular Infarction Registry

Start date: January 20, 2024
Phase:
Study type: Observational [Patient Registry]

This Study aims to provide an assessment of clinical presentation, management, hospital course, and prognosis of acute right ventricular infarction presenting with or without Inferior or infero-posterior wall Myocardial Infarction and the assessment of composite adverse clinical outcome after reperfusion in-hospital and post-discharge (in 30 Days Prognosis).

NCT ID: NCT06423989 Recruiting - Male Subfertility Clinical Trials

Role of Immunoglobulin in Male Infertility

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

to investigate the role of IVIG in male infertility and to determine its benefits in term of semen parameters and assisted reproduction outcome

NCT ID: NCT06415240 Not yet recruiting - Clinical trials for Non Pharmacological Pain Management

Effect of Facilitated Tucking and Gentle Human Touch on Procedural Pain Among Neonates

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

This is a Randomized Control Trial intended to investigate the effect of two non-pharmacological interventions on procedural pain among neonates.

NCT ID: NCT06414928 Recruiting - Heart Failure Acute Clinical Trials

Prognostic Model Heart Failure

Start date: February 14, 2024
Phase:
Study type: Observational [Patient Registry]

This study aims to determine the prognosis of heart failure in our population by using multiple validated risk scores and to evaluate the strengths of these scores in assessing prognosis with better discrimination.

NCT ID: NCT06413199 Recruiting - Resistance Training Clinical Trials

Adaptive Response of Brain Towards Resistance Training in Healthy Individuals

Start date: August 18, 2023
Phase: N/A
Study type: Interventional

The novelty of this study is to identify the mechanism of nervous system by applying resistance training intervention in healthy individuals.

NCT ID: NCT06407921 Not yet recruiting - Clinical trials for Spastic Cerebral Palsy

Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

Cerebral palsy is a non-progressive neurodevelopmental disorder, also known as littles disease.The most common cause of physical and mental disabilities in the pediatric population. Cerebral means brain and palsy means weakness or problems in muscles. Spastic cerebral palsy is the common type of cerebral palsy characterized by spasticity or high muscle tone, results in stiffness etc. This will be a randomized clinical trial, data will be collected from Sehat medical complex Lahore. Study will be conducted on 62 patients. Inclusion criteria of this study is spastic diplegic CP children with age between 6 to 12 years, with GMFCS level 1 and 2 and those who are able to Walk at least 10m with or without walking aids, able to understand command will be included. Those diplegic spastic CP who have orthopedic intervention/surgery, botulinum toxin injection within past six months, epilepsy and orthopedic conditions or medical problems that prevented children from participating in exercises will be excluded.

NCT ID: NCT06407908 Recruiting - Cerebral Palsy Clinical Trials

Urdu Translation Of Pediatric Version Of Eating Assessment Tool

Start date: May 15, 2024
Phase:
Study type: Observational

Dysphagia encompasses challenges encountered during the many stages of swallowing, including the oral phase, commencement of the swallow, pharyngeal phase, and esophageal phase. The incidence of pediatric dysphagia is on the rise as a result of advancements in medical care that have led to higher survival rates among infants born prematurely, with low birth weight, and with complex medical disorders. The Eating Assessment Tool (EAT-10), consisting of 10 items, was first developed for infant patients. (PEDI-EAT-10) will be translated into Urdu language by using forward backwards translation method. Two bilingual speakers expert in both Urdu and English languages will assist the researcher in the forward translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.

NCT ID: NCT06407895 Recruiting - Down Syndrome Clinical Trials

Effects of Lower Limb Fitness Program in Children With DS

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

Down Syndrome is a congenital disorder resulting from the trisomy of the human chromosome 21, which will determine, among other characteristics, intellectual disability and growth retardation. Reduced muscular strength, cardiovascular capacity, sleep problems, and impaired walking performance are also observed in Down syndrome participants. The estimated global prevalence is around 0.1% of live births. Children with Down's syndrome (DS) often have greater postural sway and delay in motor development. Muscle weakness and hypotonia, particularly of the lower extremities are theorized to impair their overall physical health and ability to perform daily activities. Posture, balance, and movement issues are common in children with Down syndrome. The purpose of this study is to examine the effects of Lower Limb Fitness Program on dynamic balance and mobility in children with Down Syndrome. This study explore that Lower Limb Fitness Program could improve the dynamic balance and mobility in children with DS.